Dr. Kelvin Loh

Dr. Kelvin Loh serves as managing director and CEO of IHH Healthcare, the largest private hospital operator in Asia by market capitalization. IHH operates a network of over 80 hospitals and 16,000+ beds across ten countries, anchored by flagship brands Gleneagles and Mount Elizabeth in Southeast Asia and Acibadem in Turkey. The company is a primary beneficiary of Asia's medical tourism industry, drawing patients from across the region for complex procedures at its centers of excellence. Under Loh's leadership, IHH has pursued a strategy of operational excellence — improving bed occupancy rates, expanding specialist capabilities, and integrating technology into clinical workflows. He has navigated significant complexity in managing a multi-country portfolio where healthcare regulation, insurance systems, and patient demographics vary widely. IHH's Indian operations through Gleneagles and its growing presence in Greater China represent the company's key growth vectors. Loh's decisions on hospital expansion, specialty service development, pricing power in premium segments, and management of IHH's substantial debt from prior acquisitions are the primary factors driving the stock. The structural growth of healthcare spending in emerging Asia and post-pandemic normalization of medical tourism volumes provide tailwinds that Loh is positioning IHH to capture.